文献速递乳腺US

超微血管成像血管指数在乳腺实性病灶中的可重复性与诊断性能

Reproducibility and diagnostic performance of superb microvascular Imaging's vascular index in solid breast lesions.
PubMed 文献 · Clin Radiol · 2024-12-16

该前瞻性研究对115例患者的121个乳腺实性病灶在空芯针活检前由两名观察者行BI-RADS评分并测量超微血管成像血管指数(SMI VI),恶性53个、良性68个;SMI VI的组内相关系数为0.72,AUROC仅0.61,敏感度90.4%、特异度31.9%,而BI-RADS评分AUROC为0.78、敏感度100%、特异度55.1%,提示SMI VI鉴别良恶性能力差。

要点

  • SMI VI鉴别乳腺实性病灶良恶性的AUROC为0.61,敏感度90.4%、特异度31.9%。
  • BI-RADS评分AUROC为0.78,敏感度100%、特异度55.1%、阴性预测值100%。
  • SMI VI的观察者间组内相关系数为0.72,但因其诊断性能差,可重复性在此情境下无关紧要。

核心结论

  • SMI VI在鉴别乳腺良恶性实性病灶方面性能差,因此其可重复性在此情境下无关紧要。
  • 作者认为未来研究可能发现SMI显示病灶血管性的其他用途。

研究设计与样本

  • 前瞻性研究,在空芯针活检前由两名观察者对乳腺实性病灶行BI-RADS评分并测量SMI VI。
  • 共评估115例患者的121个病灶,其中恶性53个、良性68个。
  • 以组内相关系数评估SMI VI的可重复性,以AUROC、敏感度、特异度、阳性预测值和阴性预测值评估诊断性能。

诊断标准与关键数值

  • SMI VI的组内相关系数为0.72。
  • SMI VI的AUROC为0.61,敏感度90.4%、特异度31.9%、阳性预测值50%、阴性预测值81.5%。
  • BI-RADS评分的AUROC为0.78,敏感度100%、特异度55.1%、阳性预测值62.7%、阴性预测值100%。

临床应用与阅片要点

  • 原文结论为SMI VI鉴别乳腺良恶性实性病灶性能差,未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: Superb microvascular imaging (SMI) is a new ultrasound tool that can detect small blood vessels while cancelling out artefacts. It may be useful in detecting the vascularity associated with malignant breast lesions. This study evaluated the reproducibility and diagnostic performance of SMI's Vascular Index (VI) in differentiating benign from malignant solid breast lesions.

MATERIALS AND METHODS: Solid breast lesions were prospectively assessed by two observers before core biopsy. Each lesion was given BIRADS score, and SMI VI was measured. The reproducibility and diagnostic performance of SMI VI were assessed by the intraclass correlation coefficient (ICC) and by the area under the receiver operating characteristics (AUROC) curve, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV).

RESULTS: 121 lesions in 115 patients were assessed, of which 53 were malignant and 68 benign. The ICC for SMI VI readings was 0.72. The SMI VI AUROC was 0.61, the sensitivity was 90.4%, specificity of 31.9%, PPV of 50% and NPV of 81.5%. The BIRADS scores in all lesions had an AUROC of 0.78, sensitivity of 100%, specificity of 55.1%, PPV of 62.7%, and NPV of 100%.

CONCLUSION: This is the first study to assess the reproducibility and diagnostic performance of SMI VI in differentiating benign from malignant breast lesions in a European population. We have shown that SMI VI is poor at differentiating benign from malignant breast lesions, and therefore reproducibility is irrelevant in this context. Future studies may find other uses for SMI's depiction of lesion vascularity.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Abougazia A, York J, Erdelyi G, et al. Reproducibility and diagnostic performance of superb microvascular Imaging's vascular index in solid breast lesions. Clin Radiol. 2024. PMID: 39842181. doi:10.1016/j.crad.2024.106773

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。